Efficacy and safety of fixed dose combination of Sitagliptin, metformin, and pioglitazone in type 2 Diabetes (IMPACT study): a randomized controlled trial

Efficacy and safety of fixed dose combination of Sitagliptin, metformin, and pioglitazone in type 2 Diabetes (IMPACT study): a randomized controlled trial

Abstract Background Due to the progressive decline in β-cell function, it is often necessary to utilize multiple agents with complementary mechanisms of action to address various facets and achieve glycemic control. Thus, this study aimed to evaluate the efficacy and safety of a fixed-dose combinati...

Full description

Bibliographic Details
Main Authors: Mondal Aashish, Naskar Arindam, Sheelu Shafiq Siddiqi, Deepak Bhosle, V. J. Mallikarjuna, Dange Amol, Sorate Sanket, Gavali Omkar, Patel Parth, Hasnani Dhruvi, Prasad Durga, Dalwadi Pradeep, Kumar Suresh, Pathak Vaishali, Chaudhari Mayura, Basu Indraneel, Shembalkar Jayashri, Fariooqui Arif, S. K. Raghavendra, Varade Deepak, Thakkar Ravindra, Bhanushali Shaishav, Gaikwad Vijay, Kamran Khan, V. V. Mahajani, A. D. Sharma, Mayur Mayabhate, R. R. Pawar, A. S. Aiwale, Shahavi Vinayaka
Format: Article
Language:English
Published: BMC 2024-02-01
Series:Clinical Diabetes and Endocrinology
Subjects:
Type 2 diabetes mellitus
IMPACT study
Pioglitazone
Metformin
Sitagliptin
Triple therapy
Online Access:https://doi.org/10.1186/s40842-023-00161-6

Internet

https://doi.org/10.1186/s40842-023-00161-6

Similar Items